Continuous glucose monitors (CGMs) for type 2 diabetes: When and for whom are they useful?

Continuous glucose monitors, or CGMs, give valuable, accurate insight into blood sugar levels, helping some people with diabetes make better decisions about medications, diet, exercise, and overall management. As their popularity grows, it is worth understanding who they suit best.
What are continuous glucose monitors?
A CGM tracks blood sugar continuously through the day and night. Unlike fingerstick tests, which give occasional snapshots, CGMs measure glucose every few minutes, so a person with diabetes can see whether their blood sugar is trending up or down. The devices offer more convenience, accuracy, and potential for control.
Continuous glucose monitoring has been revolutionary for some patients with diabetes, says a diabetes specialist and researcher.
How do continuous glucose monitors work?
A CGM needs three parts: a sensor, a transmitter, and a receiver. Older models keep the sensor and transmitter separate; newer ones combine them in a single device.
The sensor is a tiny catheter slipped under the skin and held in place with adhesive, changed every 10 to 14 days. Wearing it is painless, and most people forget it is there. Newer CGMs are about the size of three stacked quarters.
The sensor reads glucose levels every one to five minutes in the interstitial fluid between cells and passes them to the transmitter, which sends the readings to a receiver or smartphone app.
Advanced algorithms then analyze the data to reveal trends and patterns across the day and night. "CGMs show you where your blood sugar levels are and where they are going," the specialist says. "It shows you the graph of whether you're on the up slope or the down slope."
One caveat: there is a lag of about 20 minutes between the numbers a CGM displays and actual blood glucose levels.
Benefits of continuous glucose monitoring
With a detailed picture of glucose levels and patterns, a person with diabetes can make informed choices about diet, exercise, medication, and overall management.
CGMs can also sound alarms when glucose moves outside target ranges, allowing intervention before dangerous highs or lows. Keeping blood glucose within range reduces the risk of short-term problems like dangerously low blood sugar (hypoglycemia) and long-term complications such as cardiovascular disease, kidney damage, nerve damage, and vision problems.
Who can benefit from using CGMs?
Because it provides a continuous stream of information, a CGM is most useful for people with fluctuating glucose levels, which mostly means type 1 diabetes: it lets them, or their insulin pumps, choose the right insulin doses.
"They really do improve blood sugar control in type 1 diabetes, and more safely than we were able to do before. And that's been well shown," the specialist says.
The benefit is less clear in type 2 diabetes, which is far more common. Of the 38 million Americans with diabetes, 90% to 95% have type 2. Only a small fraction of them need complex regimens with multiple daily insulin injections.
"And for them, it's been suggested that CGM may also be helpful because they are also vulnerable to low blood sugars," the specialist explains. "In insulin-treated persons with type 2 diabetes, CGM can provide an early warning sign if their blood sugars are dropping."
"But people with type 2 diabetes, even those treated with insulin, actually have much less frequent, severe hypoglycemia compared to people with type 1 diabetes. So as a safety measure, the vast majority of people with type 2 diabetes really don't need it. They're not even on a medication that will cause low blood sugar."
Still, limited early evidence hints the devices may one day help a wider range of patients, including those with non-insulin-treated type 2 diabetes.
Are there any downsides to CGMs?
CGMs are generally safe and not hard to wear, though they stay on 24 hours a day, year-round, with sensors replaced at least every 14 days. A small fraction of users develop irritation or an allergic reaction to the adhesive. Local skin infections are extremely rare, and there really is no other complication.
Cost is the biggest concern: CGMs can run to thousands of dollars a year. Medicare covers them for eligible patients, those on insulin therapy who check blood sugar four or more times a day. Private insurance coverage varies.
As CGMs have caught on, some people without diabetes have started wearing them. "I tend to draw the line at type 1 diabetes and for selected patients with type 2," the specialist says. "For everyone else, there are almost no data to support using these devices on a regular basis."
The specialist also cautions that overuse by people who do not need CGMs could strain supply, making the devices less available to the patients with diabetes who genuinely benefit from them.




